Skip to content

Pregnancy outcomes of patients in two progestogens protocals in secretion phase after endometrial polypectomy: a comparative study

Pregnancy outcomes of patients in two progestogens protocals in secretion phase after endometrial polypectomy: a comparative study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042663
Enrollment
Unknown
Registered
2021-01-26
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial polyps

Interventions

observation group 1:taking dydrogesterone after surgery in secretory phase,20mg /d x10days
observation group 2:taking Microparticle progesterone capsules after surgery in secretory phase,200mg /d x10days
control group:only taking surgery

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients who desire to be pregnant. 2.Patients who have normal ovarian function. 3.Did not take any hormon treatment during 3 months. 4.Their husbands' sperm qulity are normal. 5.Patients who will postively try to be pregnant after surgery.

Exclusion criteria

Exclusion criteria: 1.Patients who have other infertility diseasies. Such as: tube infertile, hysteromyoma,enital malformations, adenomyosis, severe oligoasthenospermia, ect. 2.Patients who have other complications, such as: thyroid dysfunction, primary hypertension, diabetes, hyperprolactinemia, connective tissue disease complications.

Design outcomes

Primary

MeasureTime frame
pregnancy rate;eraly stage abnormal pregnancy rate;endometrial polyps recurrent rate;adverse drug reactions;

Countries

China

Contacts

Public ContactLiu Yan

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

878448385@qq.com+86 18980618569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026